![Jennie Wilborgsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennie Wilborgsson is currently Chief Operating Officer at Ascelia Pharma AB, starting in 2025.
Formerly, Ms. Wilborgsson was Head of the Global Clinical Project Management Department at KLIFO A. Education includes an undergraduate degree from the University of Lund.
| Sociétés | Poste | Début |
|---|---|---|
| ASCELIA PHARMA AB | Directeur des opérations | 01/11/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
KLIFO A/S
 KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
KLIFO A/S
KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascelia Pharma AB
 Ascelia Pharma AB Pharmaceuticals: MajorHealth Technology Operates as oncology-dedicated drug development company, which develops novel drugs to improve life expectancy | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
